Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 2 of 2 entries
Sorted by: Best Match Show Resources per page
Fast H3K9 methylation promoted by CXCL12 contributes to nuclear changes and invasiveness of T-acute lymphoblastic leukemia cells.

Oncogene

Madrazo E, González-Novo R, Ortiz-Placín C, García de Lacoba M, González-Murillo Á, Ramírez M, Redondo-Muñoz J.
PMID: 34999734
Oncogene. 2022 Jan 08; doi: 10.1038/s41388-021-02168-8. Epub 2022 Jan 08.

T-acute lymphoblastic leukemia (T-ALL) is an aggressive hematological malignancy that comprises the accumulation of malignant T-cells. Despite current therapies, failure to conventional treatments and relapse are frequent in children with T-ALL. It is known that the chemokine CXCL12 modulates...

Cite
Madrazo E, González-Novo R, Ortiz-Placín C, et al. Fast H3K9 methylation promoted by CXCL12 contributes to nuclear changes and invasiveness of T-acute lymphoblastic leukemia cells. Oncogene. 2022;doi: 10.1038/s41388-021-02168-8.
Madrazo, E., González-Novo, R., Ortiz-Placín, C., García de Lacoba, M., González-Murillo, �. �., Ramírez, M., & Redondo-Muñoz, J. (2022). Fast H3K9 methylation promoted by CXCL12 contributes to nuclear changes and invasiveness of T-acute lymphoblastic leukemia cells. Oncogene, . https://doi.org/10.1038/s41388-021-02168-8
Madrazo, Elena, et al. "Fast H3K9 methylation promoted by CXCL12 contributes to nuclear changes and invasiveness of T-acute lymphoblastic leukemia cells." Oncogene vol. (2022). doi: https://doi.org/10.1038/s41388-021-02168-8
Madrazo E, González-Novo R, Ortiz-Placín C, García de Lacoba M, González-Murillo Á, Ramírez M, Redondo-Muñoz J. Fast H3K9 methylation promoted by CXCL12 contributes to nuclear changes and invasiveness of T-acute lymphoblastic leukemia cells. Oncogene. 2022 Jan 08; doi: 10.1038/s41388-021-02168-8. Epub 2022 Jan 08. PMID: 34999734.
Copy Download .nbib Format: NLM
Differential gene expression analysis by RNA-seq reveals the importance of actin cytoskeletal proteins in erythroleukemia cells.

PeerJ

Fernández-Calleja V, Hernández P, Schvartzman JB, García de Lacoba M, Krimer DB.
PMID: 28663935
PeerJ. 2017 Jun 27;5:e3432. doi: 10.7717/peerj.3432. eCollection 2017.

Development of drug resistance limits the effectiveness of anticancer treatments. Understanding the molecular mechanisms triggering this event in tumor cells may lead to improved therapeutic strategies. Here we used RNA-seq to compare the transcriptomes of a murine erythroleukemia cell...

Cite
Fernández-Calleja V, Hernández P, Schvartzman JB, et al. Differential gene expression analysis by RNA-seq reveals the importance of actin cytoskeletal proteins in erythroleukemia cells. PeerJ. 2017;5:e3432doi: 10.7717/peerj.3432.
Fernández-Calleja, V., Hernández, P., Schvartzman, J. B., García de Lacoba, M., & Krimer, D. B. (2017). Differential gene expression analysis by RNA-seq reveals the importance of actin cytoskeletal proteins in erythroleukemia cells. PeerJ, 5e3432. https://doi.org/10.7717/peerj.3432
Fernández-Calleja, Vanessa, et al. "Differential gene expression analysis by RNA-seq reveals the importance of actin cytoskeletal proteins in erythroleukemia cells." PeerJ vol. 5 (2017): e3432. doi: https://doi.org/10.7717/peerj.3432
Fernández-Calleja V, Hernández P, Schvartzman JB, García de Lacoba M, Krimer DB. Differential gene expression analysis by RNA-seq reveals the importance of actin cytoskeletal proteins in erythroleukemia cells. PeerJ. 2017 Jun 27;5:e3432. doi: 10.7717/peerj.3432. eCollection 2017. PMID: 28663935; PMCID: PMC5490462.
Copy Download .nbib Format: NLM
Showing 1 to 2 of 2 entries